William Aird: Understanding the Ferritin Surge After IV Iron
William Aird, Professor of Medicine at Harvard Medical School, posted on X:
”IV Iron and Ferritin
I recently posted a question about the spike in serum ferritin after IV iron. It can shoot from <10 to >1000, yet transferrin saturation (TSAT) only rises to normal — it barely moves.
What’s going on? This is macrophage physiology in action.
Step 1 – Uptake
IV iron–carbohydrate complexes (e.g., iron dextran) are endocytosed by macrophages in the liver, spleen, and marrow. Inside, the iron is released and floods the labile Fe²⁺ pool, the cell’s internal “iron bank.”
Step 2 – Ferritin synthesis explodes
- High intracellular Fe²⁺ flips the IRP–IRE switch, unleashing translational ferritin synthesis.
- Cytokines add a transcriptional boost.
- Ferritin production ↑↑ → serum ferritin rises via a regulated, non-classical secretion pathway.
Step 3 – The lab pattern
During the first 1–3 weeks after infusion:
- Ferritin ↑↑ (macrophage storage + secretion)
- TSAT ↑ to normal (as a small fraction of iron slowly transfers to transferrin)
Step 3 (cont’d)
Fe release is slow, because hepcidin levels rise after IV iron, throttling ferroportin and keeping iron temporarily trapped in macrophages (only a slow trickle of iron is exported via ferroportin into the bloodstream). This is redistribution, not overload.
Step 4 – Resolution
- As macrophages slowly export iron via ferroportin, their intracellular iron falls. The IRP–IRE system re-engages, ferritin synthesis drops, cytokine signals fade.
- Serum ferritin settles to a new, steady level.
Bottom line:
Ferritin spikes after IV iron because:
- Macrophages are suddenly iron-loaded → ↑ ferritin translation
- Cytokines transiently ↑ transcription
- Ferritin is secreted into plasma
As iron normalizes, ferritin synthesis and secretion taper.
Clinical takeaway: If you see ferritin >1000 and TSAT merely normal after IV iron, think macrophage response, not iron overload. Ferritin is telling you iron has arrived; it just hasn’t moved on yet.”

Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
